Emma Persson
Company: Argenx
Job title: Clinical Scientist
Seminars:
Phase 2 Clinical Study into Empasiprubart for Multifocal Motor Neuropathy 11:00 am
Targeting C2 to inhibit function and downstream complement activation Reducing tissue inflammation and adaptive immune responses in autoimmune indications Clinical update on Empasiprubart for MMNRead more
day: Conference Day Two